American Association for Clinical Chemistry
Better health through laboratory medicine
NACB - Scientific Shorts
NACB - Scientific Shorts (formerly NACB Blog)
By Patricia M. Jones, PhD, DABCC, FACB
PermalinkRecommendFacebookEmailComments
​In the world of medicine, and especially laboratory medicine, new technologies with new and usually improved capabilities are arising far faster than we can keep up with them.   Those new technologies sometimes revolutionize not only the field they spring up in, but also other, originally unrelate...(Read More)
By Dustin Bunch
PermalinkRecommendFacebookEmailComments
Matrix effects are regarded as the Achilles’ heel of clinical liquid chromatography tandem mass spectrometry (LC-MS/MS). Our laboratory has been developing clinical LC-MS/MS assays since 2006. To aid with assay validation, a protocol was established that included a serious investigation of matrix e...(Read More)
By Xuan Mu, PhD
PermalinkRecommendFacebookEmailComments
Cystic Fibrosis (CF) is one of the most common inherited disorders, primarily caused by mutations of a single gene, CF transmembrane conductance regulator (CFTR). An estimated 1.2 million individuals are tested for CF every year in the US (1). Over 127 mutations are associated with the pathogenesis...(Read More)
By Angela M. Ferguson, Ph.D., DABCC, FACB
PermalinkRecommendFacebookEmailComments
Clinical Impact of the BuBc Slide RecalibOrtho Clinical Diagnostics’ method of measuring bilirubin is unique when compared to other commonly used methods.  The difference between the methods is the way different bilirubin fractions are measured or calculated.  Total bilirubin is measured with the T...(Read More)
1 - 4 Next